Last reviewed · How we verify
Pemphigus foliaceus
Approved treatments
- Mabthera · Roche
- Mabthera · Roche
Monoclonal antibody targeting CD20 on B-lymphocytes, mediating cell lysis via CDC and ADCC. - Mabthera · Roche
Mabthera works by binding to the CD20 antigen on B-lymphocytes, triggering their destruction.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pemphigus foliaceus patent landscape — cliff calendar, originator estates, attackable patents
- Pemphigus foliaceus treatment landscape brief
- Pemphigus foliaceus treatment updates RSS
Frequently asked questions about Pemphigus foliaceus
What drugs treat Pemphigus foliaceus?
Tracked treatments include Mabthera.
What is the treatment for Pemphigus foliaceus?
Standard treatment for Pemphigus foliaceus includes Mabthera. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pemphigus foliaceus patent cliff · Pemphigus foliaceus CI report
- Treatment: Mabthera · Roche
- Treatment: Mabthera · Roche
- Treatment: Mabthera · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing